Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA
about
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA
description
article
@en
im Jahr 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Improved lung function and pat ...... d in Asia, Europe, and the USA
@en
Improved lung function and pat ...... d in Asia, Europe, and the USA
@nl
type
label
Improved lung function and pat ...... d in Asia, Europe, and the USA
@en
Improved lung function and pat ...... d in Asia, Europe, and the USA
@nl
prefLabel
Improved lung function and pat ...... d in Asia, Europe, and the USA
@en
Improved lung function and pat ...... d in Asia, Europe, and the USA
@nl
P2093
P2860
P356
P1476
Improved lung function and pat ...... d in Asia, Europe, and the USA
@en
P2093
Andrea Maes
Colin Reisner
David J Collier
Koichi Nishi
Rongchang Chen
Samir Arora
Shahid Siddiqui
Ubaldo J Martin
Yasuhiro Gon
P2860
P304
P356
10.2147/COPD.S171835
P407
P577
2018-01-01T00:00:00Z